当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Roald Dahl
This qualitative investigation explores the medication experience and factors influencing adherence to oral targeted therapy among lung cancer survivors. Through individual interviews and focus group discussions, lung cancer survivors prescribed oral targeted therapy were asked about their experiences and the factors impacting their adherence. Thematic analysis was used to identify recurring themes and patterns in the data. The findings shed light on participants’ perspectives on the medication, including perceptions of benefits and risks, experiences with side effects, and interactions with healthcare providers. Factors influencing adherence, such as financial constraints, medication reminders, social support, and information provided by healthcare professionals, were also identified. The insights gained from this study can inform healthcare providers in developing strategies to support patients in effectively adhering to oral targeted therapies. Interventions, educational programs, and supportive care services can be tailored to address the identified challenges and improve medication adherence among lung cancer survivors.